Live feed16:05:55·51dINSIDERFilingChief Technology Officer Plavsic Mark was granted 62,339 shares, increasing direct ownership by 34% to 243,736 units (SEC Form 4)AURA· Aura Biosciences Inc.Health CareOriginal source